Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers

Discover Pediatric Collections on COVID-19 and Racism and Its Effects on Pediatric Health

American Academy of Pediatrics
Article

Risk of Immune Thrombocytopenic Purpura After Measles-Mumps-Rubella Immunization in Children

Eric K. France, Jason Glanz, Stanley Xu, Simon Hambidge, Kristi Yamasaki, Steve B. Black, Michael Marcy, John P. Mullooly, Lisa A. Jackson, James Nordin, Edward A. Belongia, K. Hohman, Robert T. Chen, Robert Davis and ; for the Vaccine Safety Datalink Team
Pediatrics March 2008, 121 (3) e687-e692; DOI: https://doi.org/10.1542/peds.2007-1578
Eric K. France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason Glanz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stanley Xu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Hambidge
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristi Yamasaki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steve B. Black
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Marcy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John P. Mullooly
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa A. Jackson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Nordin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward A. Belongia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Hohman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert T. Chen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Davis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Comments
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Download PDF

Abstract

BACKGROUND. The measles-mumps-rubella vaccine has been associated with immune thrombocytopenia purpura in 2 small studies.

METHODS. By using the Vaccine Safety Datalink, we identified measles-mumps-rubella–vaccinated children aged 1 to 18. A case of immune thrombocytopenia purpura was defined as a patient with a platelet count of ≤50000/μL with clinical bleeding and normal red and white blood cell indices. The immune thrombocytopenia purpura incidence rates during exposed (42 days after vaccination) and unexposed time periods were determined. A retrospective cohort of vaccinated children was used to determine incident rate ratios for children aged 1 to 18 years, 12 to 23 months, and 12 to 15 months.

RESULTS. A total of 1036689 children received 1107814 measles-mumps-rubella vaccinations; there were 259 confirmed patients with immune thrombocytopenia purpura. Because only 5 exposed cases occurred after age 2, analyses were limited to children aged 12 to 23 months. Exposed patients aged 12 to 23 months had lower median platelet counts than those who were unexposed and had similar median duration of illness (11 vs 10 days). The incident rate ratio was highest for children aged 12 to 15 months at 7.10. The incident rate ratio for boys aged 12 to 15 months was 14.59, and the incident rate ratio for girls in the same age group was 3.22. Seventy-six percent of immune thrombocytopenia purpura cases in children aged 12 to 23 months were attributable to measles-mumps-rubella vaccination. This vaccine causes 1 case of immune thrombocytopenia purpura per every 40000 doses.

CONCLUSION. Measles-mumps-rubella vaccine that is given in the second year of life is associated with an increased risk of immune thrombocytopenia purpura.

  • immune thrombocytopenia purpura
  • children
  • measles-mumps-rubella vaccines
  • thrombocytopenia
  • Accepted November 30, 2007.
  • Copyright © 2008 by the American Academy of Pediatrics

Individual Login

Log in
You will be redirected to aap.org to login or to create your account.

Institutional Login

via Institution

You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.

Log in through your institution

If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

Offer Reprints

PreviousNext
Back to top

Advertising Disclaimer »

In this issue

Pediatrics
Vol. 121, Issue 3
March 2008
  • Table of Contents
  • Index by author
View this article with LENS
PreviousNext
Email Article

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Risk of Immune Thrombocytopenic Purpura After Measles-Mumps-Rubella Immunization in Children
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Request Permissions
Article Alerts
Log in
You will be redirected to aap.org to login or to create your account.
Or Sign In to Email Alerts with your Email Address
Citation Tools
Risk of Immune Thrombocytopenic Purpura After Measles-Mumps-Rubella Immunization in Children
Eric K. France, Jason Glanz, Stanley Xu, Simon Hambidge, Kristi Yamasaki, Steve B. Black, Michael Marcy, John P. Mullooly, Lisa A. Jackson, James Nordin, Edward A. Belongia, K. Hohman, Robert T. Chen, Robert Davis
Pediatrics Mar 2008, 121 (3) e687-e692; DOI: 10.1542/peds.2007-1578

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Risk of Immune Thrombocytopenic Purpura After Measles-Mumps-Rubella Immunization in Children
Eric K. France, Jason Glanz, Stanley Xu, Simon Hambidge, Kristi Yamasaki, Steve B. Black, Michael Marcy, John P. Mullooly, Lisa A. Jackson, James Nordin, Edward A. Belongia, K. Hohman, Robert T. Chen, Robert Davis
Pediatrics Mar 2008, 121 (3) e687-e692; DOI: 10.1542/peds.2007-1578
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Print
Download PDF
Insight Alerts
  • Table of Contents

Jump to section

  • Article
    • Abstract
    • METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSIONS
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • Comments

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Vaccination and Risk of Childhood IgA Vasculitis
  • Recurrent Immune Thrombocytopenia After Influenza Vaccination: A Case Report
  • Safety of Measles-Containing Vaccines in 1-Year-Old Children
  • The Risk of Immune Thrombocytopenic Purpura After Vaccination in Children and Adolescents
  • The ITP syndrome: pathogenic and clinical diversity
  • Google Scholar

More in this TOC Section

  • Predictive Models of Neurodevelopmental Outcomes After Neonatal Hypoxic-Ischemic Encephalopathy
  • A Technology-Assisted Language Intervention for Children Who Are Deaf or Hard of Hearing: A Randomized Clinical Trial
  • Standard Versus Long Peripheral Catheters for Multiday IV Therapy: A Randomized Controlled Trial
Show more Articles

Similar Articles

Subjects

  • Infectious Disease
    • Infectious Disease
    • Vaccine/Immunization
  • Journal Info
  • Editorial Board
  • Editorial Policies
  • Overview
  • Licensing Information
  • Authors/Reviewers
  • Author Guidelines
  • Submit My Manuscript
  • Open Access
  • Reviewer Guidelines
  • Librarians
  • Institutional Subscriptions
  • Usage Stats
  • Support
  • Contact Us
  • Subscribe
  • Resources
  • Media Kit
  • About
  • International Access
  • Terms of Use
  • Privacy Statement
  • FAQ
  • AAP.org
  • shopAAP
  • Follow American Academy of Pediatrics on Instagram
  • Visit American Academy of Pediatrics on Facebook
  • Follow American Academy of Pediatrics on Twitter
  • Follow American Academy of Pediatrics on Youtube
  • RSS
American Academy of Pediatrics

© 2021 American Academy of Pediatrics